Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro

International Journal of Food Microbiology

Volumn 63, Issue 1-2, 2001, Pages 81-90

  Zhou, J S ^a   Gopal, P K ^b   Gill, H S ^a,b  

^a MASSEY UNIVERSITY   (New Zealand)

^b NEW ZEALAND DAIRY RESEARCH INSTITUTE   (New Zealand)

Author keywords

Glycoprotein; Lactic acid bacteria; Mucin degradation; Probiotics

Indexed keywords

CARBOHYDRATE; GLYCOPROTEIN; MUCIN; PROTEIN;

ARTICLE; BIFIDOBACTERIUM; BIODEGRADATION; GASTROINTESTINAL TRACT; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ANAEROBIOSIS; BIFIDOBACTERIUM; CARBOHYDRATES; COLONY COUNT, MICROBIAL; CULTURE MEDIA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GASTRIC MUCIN; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; MOLECULAR WEIGHT; PROBIOTICS; PROTEINS; TEMPERATURE; TIME FACTORS;

EID: 0035931661     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1605(00)00398-6     Document Type: Article

References (51)

1. Lactobacillus casei infection in an AIDS patient [Letter]
2. Lactic acid bacteria and human clinical infection
3. Structure of gastrointestinal mucus glycoproteins and the viscous and gel-forming properties of mucus
4. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019)
5. Lactobacillemia - report of nine cases. Important clinical and therapeutic considerations
6. Gastrointestinal surface protection and mucosa reconditioning
7. The role of probiotic cultures in the prevention of colon cancer
8. Isolation and characterisation of glycoproteins
9. Carbohydrate analysis - a practical approach
10. Bacterial adhesion to and penetration of intestinal mucus in vitro
11. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase
12. Degradation by bacterial enzymes of colonic mucus from normal subjects and patients with inflammatory bowel disease: the role of sialic acid metabolism and the detection of a novel O-acetylsialic acid esterase
13. Mucus glycoproteins and their role in colorectal disease
14. Safety of probiotic bacteria
15. Scandinavia - nursery for probiotic products
16. History and development of probiotics
17. One-dimensional gel electrophoresis of proteins
18. Safety of lactic acid bacteria and their occurrence in human clinical infections
19. Stimulation of the immune system by lactic cultures
20. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019)
21. Probiotics and gastrointestinal health
22. Mucin degradation in human colon ecosystems
23. Mucin degradation in human colon ecosystems - isolation and properties of faecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins
24. Probiotic foods - a new opportunity
25. The use of probiotics in paediatrics
26. Safety considerations regarding probiotic strains - conclusions of two specialist workshops
27. Probiotic bacteria: today and tomorrow
28. Formation of glycoprotein degrading enzymes by Bacteroides fragilis
29. Lactobacillus endocarditis caused by a probiotic organism
30. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG
31. Demonstration of safety of probiotics
32. Mucin degradation in human colon ecosystems - faecal population densities of mucin degrading bacterial estimated by a 'most probable number' method
33. Probiotic spectra of lactic acid bacteria (LAB)
34. Establishment of Lactobacillus and Bifidobacterium species in germ-free mice and their influence on some microflora-associated characteristics
35. The effect of probiotics on Clostridium difficile diarrhea
36. Selection and characterisation of Lactobacillus and Bifidobacterium strains for use as probiotics
37. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG
38. Special yoghurts - the potential health benefits
39. Probiotics and benefits to human health - the evidence in favour
40. Degradation of intestinal glycoproteins by Bacteroides vulgatus
41. Inability of Lactobacillus casei strain GG, L. acidophilus and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins
42. Probiotics and infectious diarrhea
43. Safety assessment of Lactobacillus strain GG (ATCC 53103)
44. Lactobacillus GG (Gefilac™) fermented whey drink and yoghurt - new clinically tested dairy products to promote health
45. Demonstration of safety of probiotics - a review
46. Overview of functional foods: emphasis on probiotic bacteria
47. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice
48. Colonic mucin glycoproteins in health and disease
49. Intestinal mucin inhibits adhesion of human enteropathogenic Escherichia coli to Hep-2 cells
50. Breakdown of mucin and plant polysaccharides in the human colon